How Much Does Targeted Genomic Sequence Analysis of 83 or More Genes in Cell Free Circulating Cost?
Also known as: Targeted genomic sequence analysis of 83 or more genes in cell free circulating (CPT 0326U)
Targeted Genomic Sequence Analysis of 83 or More Genes in Cell Free Circulating (CPT 0326U) costs $5,000 at Medicare rates.
Procedures Commonly Done Together
These procedures are frequently performed alongside Targeted genomic sequence analysis of 83 or more genes in cell free circulating
How to Reduce Your Cost for Targeted genomic sequence analysis of 83 or more genes in cell free circulating
Practical tips that can save you hundreds or thousands of dollars
- 1 Ask about cash-pay discounts
Many hospitals and clinics offer 20-40% discounts for self-pay patients. Always ask before scheduling.
- 2 Compare facility vs. office setting costs
Some procedures cost significantly less in an office setting than a hospital. Ask your provider about options.
- 3 Shop around — costs vary significantly
Costs can vary 2-3x between providers in the same city. Get quotes from multiple facilities.
Related Procedures
Similar procedures in the same category or body system
Frequently Asked Questions
How much does Targeted genomic sequence analysis of 83 or more genes in cell free circulating cost?
The Medicare facility rate for Targeted genomic sequence analysis of 83 or more genes in cell free circulating is $5,000. Commercial insurance rates typically range from 150% to 250% of Medicare (varies by plan).
How much does Targeted genomic sequence analysis of 83 or more genes in cell free circulating cost without insurance?
Without insurance, the cost of Targeted genomic sequence analysis of 83 or more genes in cell free circulating can range from 150% of Medicare to 500% of Medicare depending on the facility. Many hospitals and clinics offer self-pay discounts of 20-40% off their chargemaster price. Always ask about cash pricing before your visit.
Does insurance cover Targeted genomic sequence analysis of 83 or more genes in cell free circulating?
Most commercial health insurance plans and Medicare cover Targeted genomic sequence analysis of 83 or more genes in cell free circulating when ordered by a physician for a medically necessary reason. Your out-of-pocket cost depends on your plan's deductible, copay/coinsurance structure, and whether you use an in-network provider. Check with your insurance company before scheduling to confirm coverage and get a cost estimate.
Why does the cost vary so much by location?
Medicare adjusts payments using Geographic Practice Cost Indices (GPCIs) that reflect local differences in physician work costs, practice expenses, and malpractice insurance. Manhattan, San Francisco, and other high-cost areas pay significantly more than rural regions. Commercial insurers follow similar geographic patterns.